These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Reversible agranulocytosis associated with oral terbinafine in a pediatric patient. Aguilar C; Mueller KK J Am Acad Dermatol; 2001 Oct; 45(4):632-4. PubMed ID: 11568763 [TBL] [Abstract][Full Text] [Related]
11. Inappropriate use of oral terbinafine in family practice. Wilcock M; Hartley J; Gould D Pharm World Sci; 2003 Feb; 25(1):25-6. PubMed ID: 12661473 [TBL] [Abstract][Full Text] [Related]
12. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939 [TBL] [Abstract][Full Text] [Related]
13. The treatment of dermatophytosis: safety considerations. Smith EB J Am Acad Dermatol; 2000 Nov; 43(5 Suppl):S113-9. PubMed ID: 11044286 [No Abstract] [Full Text] [Related]
15. On the EM algorithm for overdispersed count data. McLachlan GJ Stat Methods Med Res; 1997 Mar; 6(1):76-98. PubMed ID: 9185291 [TBL] [Abstract][Full Text] [Related]
16. [Terbinafine and warfarin interaction]. Schmutz JL; Barbaud A; Tréchot P Ann Dermatol Venereol; 1999 May; 126(5):463. PubMed ID: 10434116 [No Abstract] [Full Text] [Related]
17. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis. Korting HC; Kiencke P; Nelles S; Rychlik R Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018 [TBL] [Abstract][Full Text] [Related]
18. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week). Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971 [TBL] [Abstract][Full Text] [Related]
19. Frequentist performance of Bayesian confidence intervals for comparing proportions in 2 x 2 contingency tables. Agresti A; Min Y Biometrics; 2005 Jun; 61(2):515-23. PubMed ID: 16011699 [TBL] [Abstract][Full Text] [Related]
20. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US. Van Duyn Graham L; Elewski BE Mycoses; 2011 Nov; 54(6):e679-85. PubMed ID: 21668517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]